Year |
Citation |
Score |
2019 |
Hasbi A, Madras BK, Bergman J, Kohut S, Lin Z, Withey SL, George SR. Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons. Iscience. 23: 100794. PMID 31972514 DOI: 10.1016/J.Isci.2019.100794 |
0.438 |
|
2018 |
Canseco-Alba A, Schanz N, Sanabria B, Zhao J, Lin Z, Liu QR, Onaivi ES. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons. Behavioural Brain Research. PMID 30508607 DOI: 10.1016/j.bbr.2018.11.043 |
0.334 |
|
2017 |
Liu QR, Canseco-Alba A, Zhang HY, Tagliaferro P, Chung M, Dennis E, Sanabria B, Schanz N, Escosteguy-Neto JC, Ishiguro H, Lin Z, Sgro S, Leonard CM, Santos-Junior JG, Gardner EL, et al. Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. Scientific Reports. 7: 17410. PMID 29234141 DOI: 10.1038/S41598-017-17796-Y |
0.318 |
|
2016 |
Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, Lin Z, Tesar P, Hoffer BJ, Luo Y. Lower Dopamine D2 Receptor Expression Levels in Human Dopaminergic Neurons Derived From Opioid-Dependent iPSCs. The American Journal of Psychiatry. 173: 429-431. PMID 27035534 DOI: 10.1176/Appi.Ajp.2015.15121545 |
0.323 |
|
2012 |
Zhao Y, Zhou Y, Xiong N, Lin Z. Identification of an intronic cis-acting element in the human dopamine transporter gene. Molecular Biology Reports. 39: 5393-9. PMID 22160470 DOI: 10.1007/s11033-011-1339-4 |
0.338 |
|
2011 |
Xiong N, Xiong J, Khare G, Chen C, Huang J, Zhao Y, Zhang Z, Qiao X, Feng Y, Reesaul H, Zhang Y, Sun S, Lin Z, Wang T. Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. Plos One. 6: e20677. PMID 21677777 DOI: 10.1371/journal.pone.0020677 |
0.302 |
|
2006 |
Madras BK, Fahey MA, Goulet M, Lin Z, Bendor J, Goodrich C, Meltzer PC, Elmaleh DR, Livni E, Bonab AA, Fischman AJ. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo. The Journal of Pharmacology and Experimental Therapeutics. 319: 570-85. PMID 16885433 DOI: 10.1124/Jpet.106.105312 |
0.501 |
|
2006 |
Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. The Journal of Pharmacology and Experimental Therapeutics. 319: 561-9. PMID 16885432 DOI: 10.1124/Jpet.106.106583 |
0.477 |
|
2004 |
Dohi T, Kitayama S, Morioka N, Kumagai K, Mitsuhata C, Morita K, Kozai K, Lin Z, Uhl GR. Regulation of dopamine and MPP+ transport by catecholamine transporters. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 24: 43-7. PMID 15164608 |
0.327 |
|
2003 |
Lin Z, Uhl GR. Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities. The Pharmacogenomics Journal. 3: 159-68. PMID 12815364 DOI: 10.1038/sj.tpj.6500169 |
0.374 |
|
2002 |
Itokawa M, Lin Z, Uhl GR. Dopamine efflux via wild-type and mutant dopamine transporters: alanine substitution for proline-572 enhances efflux and reduces dependence on extracellular dopamine, sodium and chloride concentrations. Brain Research. Molecular Brain Research. 108: 71-80. PMID 12480180 DOI: 10.1016/S0169-328X(02)00515-6 |
0.367 |
|
Show low-probability matches. |